Since their introduction in the 1960s, anthracyclines have been a significant breakthrough in
oncology, introducing dramatic changes in the treatment of solid and hematologic …

Simple Summary Anthracycline drugs, as a class of commonly used antitumor
chemotherapeutics, play a significant role in the treatment of various cancers. However, they …

Abstract Purpose of Review This review explores the cardiovascular toxicity associated with
cancer therapies, emphasizing the significance of the growing field of cardio-oncology. It …

Over the past decade, genome-scale molecular profiling of large childhood cancer
survivorship cohorts has led to unprecedented advances in our understanding of the genetic …

Defined as scarce expression of hormone receptors and human epidermal growth factor
receptor 2, triple-negative breast cancer (TNBC) is labeled as the most heterogeneous …

In recent years, with advancements in medicine, the survival period of patients with tumours
has significantly increased. The adverse effects of tumour treatment on patients, especially …

How do we protect the heart during chemotherapy with the anthracycline drug class?
Tackling this question, Liu et al. combined pluripotent stem cell models, CRISPR genetic …

Anthracyclines can result in cardiotoxic effects, which can occur acutely and chronically.
Patients with breast cancer, lymphoma, sarcoma, and leukemia are still treated with …

Les progrès en oncologie pédiatrique ont conduit à améliorer le pronostic des patients
traités pour un cancer de l'enfant ou de l'adolescent avec une survie à 5 ans supérieure à …